Decision Making Q16:
Dilemma: A prominent pharmaceutical corporation develops a breakthrough oncology drug but prices it so exorbitantly that uninsured cancer patients cannot afford treatment, resulting in preventable deaths. Company executives argue high pricing is necessary to recoup billions in R&D and fund future drug pipelines. As corporate head of bioethics, what is the most defensible pricing strategy?
Dilemma: A prominent pharmaceutical corporation develops a breakthrough oncology drug but prices it so exorbitantly that uninsured cancer patients cannot afford treatment, resulting in preventable deaths. Company executives argue high pricing is necessary to recoup billions in R&D and fund future drug pipelines. As corporate head of bioethics, what is the most defensible pricing strategy?